Companies · Other Health Care

Calypso Medical Technologies Inc

SEATTLE · Other Health Care

Diligence memoA one-page analyst read on Calypso Medical Technologies Inc — recommendation, valuation, rhythm, risks.
$69.5M
Total raised · real
6
Rounds
0.9×
Latest step-up
Top 7%
Sector rank · raised
Series C
Latest stage · inferred · Thu Jan 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)

Calypso Medical Technologies Inc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.15× the median modeled value of Series C Other Health Care companies in 2010–2012 (24 peers) — value vs value, same stage and era.
Dormant
  • Last raise 15.5 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Calypso Medical Technologies Inc is one of 5377 Other Health Care companies tracked from SEATTLE. By capital raised it ranks among the largest (ahead of 94% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeed · 2009-04-22 Raised $2.9M (real) Modeled valuation $71M (est)$2.9M$71MSeed2009Seed · 2009-04-22 Raised $2.6M (real) Modeled valuation $64M (est)$2.6M$64MSeed2009Seed · 2009-04-22 Raised $1.8M (real) Modeled valuation $45M (est)$1.8M$45MSeed2009Series C · 2009-09-15 Raised $48M (real) Modeled valuation $1.1B (est)$48M$1.1BSeries C2009Series C · 2011-01-06 Raised $7.5M (real) Modeled valuation $171M (est)$7.5M$171MSeries C2011Series C · 2011-01-06 Raised $6.4M (real) Modeled valuation $146M (est)$6.4M$146MSeries C2011+$2.6M+$1.8M+$48M+$7.5M+$6.4MCumulative $70M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.9M · 2009
Seed extension$2.6M · 2009
Seed extension$1.8M · 2009
Series C$48.4M · 2009no Series A / Series B on file
Series C extension$7.5M · 2011
Series C extension$6.4M · 2011

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.

Modeled valuation trajectory
$171.5M
Base estimate est.
$27.3M
Conservative case
$451.8M
Upside case
$50.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $71.1M · 2009-04-222009Seed · modeled $64.2M · 2009-04-22Seed · modeled $44.7M · 2009-04-22Series C · modeled $1.1B · 2009-09-15Series C · modeled $171.5M · 2011-01-06Series C · modeled $146.5M · 2011-01-062011
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
6.0 yr
Elapsed time used
15.5 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
4 mo
Avg between rounds
$40.7M/yr
Capital velocity
17.2 yr
On record since
2009
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 29× above median
This company$69.5M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.1× of median
This company$6.4M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 7.8× above median
This company$171.5M
Sector median$22.1M

Raised more than 94% of sector peers (real $). Modeled value above 86% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #19 of 24.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Castlight Health, Inc. · Series C Raised $177.0M · modeled $2.3B (est)Msd Parent Corp. · Series C Raised $98.8M · modeled $2.3B (est)Pentec Healthcare Infusions, Inc. · Series C Raised $98.8M · modeled $2.3B (est)OraPharma Topco Holdings, Inc. · Series C Raised $88.5M · modeled $2.0B (est)Cameron Health, Inc. · Series C Raised $82.7M · modeled $1.9B (est)UANT Ventures, L.P. · Series C Raised $120.4M · modeled $1.6B (est)Sientra, Inc. · Series C Raised $65.0M · modeled $1.5B (est)Moksha8 Inc · Series C Raised $93.5M · modeled $1.4B (est)FC Investors XXI LLC · Series C Raised $60.0M · modeled $1.4B (est)Cardiomems Inc · Series C Raised $139.6M · modeled $1.4B (est)Homecare Homebase, LLC · Series C Raised $56.5M · modeled $1.3B (est)Precision Dermatology, Inc. · Series C Raised $103.4M · modeled $1.3B (est)Calypso Medical Technologies Inc (this company) Raised $69.5M · modeled $171.5M (est)Calypso Medical Technologies Inc
CompanyStageRaised · realValue · estvs peer med.
Castlight Health, Inc.Series C$177.0M$2.3B1.94×
Msd Parent Corp.Series C$98.8M$2.3B1.92×
Pentec Healthcare Infusions, Inc.Series C$98.8M$2.3B1.92×
OraPharma Topco Holdings, Inc.Series C$88.5M$2.0B1.72×
Cameron Health, Inc.Series C$82.7M$1.9B1.61×
UANT Ventures, L.P.Series C$120.4M$1.6B1.33×
Sientra, Inc.Series C$65.0M$1.5B1.26×
Moksha8 IncSeries C$93.5M$1.4B1.19×
FC Investors XXI LLCSeries C$60.0M$1.4B1.17×
Cardiomems IncSeries C$139.6M$1.4B1.17×
Homecare Homebase, LLCSeries C$56.5M$1.3B1.10×
Precision Dermatology, Inc.Series C$103.4M$1.3B1.07×
Calypso Medical Technologies Inc this companySeries C$69.5M$171.5M0.15×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.9M2009-04-22$14.3M$71.1M90%
Seed$2.6M2009-04-22$13.0M$64.2M90%
Seed$1.8M2009-04-22$9.0M$44.7M90%
Series C$48.4M2009-09-15$322.4M$1.1B90%
Series C$7.5M2011-01-06$50.0M$171.5M90%
Series C$6.4M2011-01-06$42.7M$146.5M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.9M2009-04-22
    • First recorded raise — entered as Seed.
  2. Seed$2.6M2009-04-22
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  3. Seed$1.8M2009-04-22
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× smaller than the prior — bridge or down round.
  4. Series C$48.4M2009-09-15
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 26.8× larger than the prior — scaling up.
  5. Series C$7.5M2011-01-06
    • Raised 16 mo later, in step with the ~14 mo sector norm.
    • Round 6.4× smaller than the prior — bridge or down round.
  6. Series C$6.4M2011-01-06
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
Intelligence
2011 ~Q2
Modeled next raise · ~4mo cadence
$6.4M
Modeled next size est.range $6.4M$10.3M
0.9×
Last step-up
$40.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Gill7 other2009-04
Alan Levy6 other2009-04
Jeanne Cunicelli6 other2009-04
John Freund6 other2009-09
Michael Sweeney6 other2009-09
Ross Jaffe6 other2009-04
Alan Frazier4 other2011-01
Eric Meier2 other2009-04
Ron Berenson1 other2009-04
Steve Tallman1 other2009-04
Ed Vertatschitsch2011-01
Russ Rottiers2009-04
Trever Moody2009-04
Registry & provenance

Calypso Medical Technologies Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1125941
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Autonomic Technologies IncOther Health CareSeries C$125.6M$1.1Bnetwork1 shared operator · same sector · same stage
Relievant MedSystems IncOther Health CareSeries C$200.1M$523.3Mnetwork1 shared operator · same sector · same stage
Chrono Therapeutics Inc.Other Health CareSeries B$51.4M$833.2Mnetwork1 shared operator · same sector
TW-NHME Holdings Corp.Other Health CareSeries C$64.3M$171.5Msame sector · same stage
Nanostim IncOther Health CareSeries A$48.0M$191.7Mnetwork1 shared operator · same sector
IDev Technologies IncOther Health CareSeries B$44.2M$18.4Mnetwork1 shared operator · same sector
Cytrellis Biosystems, Inc.Other Health CareSeries C$82.7M$182.1Msame sector · same stage
Center for Orthopedic & Research Excellence, Inc.Other Health CareSeries B$38.2M$48.7Mnetwork1 shared operator · same sector
Frequently asked
How much funding has Calypso Medical Technologies Inc raised?
Calypso Medical Technologies Inc has raised approximately $69.5M in disclosed capital across 6 recorded financing rounds, aggregated from public filings.
What is Calypso Medical Technologies Inc's estimated valuation?
Provath's modeled valuation for Calypso Medical Technologies Inc is approximately $171.5M (modeled range $27.3M–$451.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Calypso Medical Technologies Inc at?
Calypso Medical Technologies Inc's latest modeled financing stage is Series C. Its most recent recorded round closed around Thu Jan 06.
What does Calypso Medical Technologies Inc do and where is it based?
Calypso Medical Technologies Inc operates in the Other Health Care sector, based in SEATTLE.
Explore related

See where Calypso Medical Technologies Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Calypso Medical Technologies Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.